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Background
Lipids are an important structural component of the cell,
making up the cell’s membranes. Cancer cells need lipids
in large quantities to enable their rapid proliferation. Here
we aim to quantitatively evaluate the routes by which
cancer cells acquire lipids (de novo synthesis, uptake from
environment) under various conditions (specific oncogenic
activations, nutrient availability). We developed a mass
spectrometry-based method to quantitate the relative con-
tributions of the various fatty acid acquisition routes and
applied this and other methods to study fatty acid metabo-
lism in cell lines, both in vitro and in vivo.
Materials and methods
Analysis of fatty acid acquisition routes was done by com-
bining
13C-tracers with liquid-chromatography mass spec-
trometry (LC-MS): cells were grown in medium with
uniformly labeled
13C-glucose and
13C-glutamine. Fatty
acid samples were generated by saponifying (hydrolyzing)
whole cell lipid extracts from these cultured cells, and
were analyzed by high resolution LC-MS. Fluxes and rela-
tive contributions of fatty acid metabolic events (de novo
synthesis, uptake, elongation, desaturation) were com-
puted from the observed isotopic patterns. In addition,
intact lipid (lipidomics) measurements were done by high
resolution LC-MS. These approaches were applied to mul-
tiple cell lines with a variety of oncogenic lesions: isogenic
transformed baby mouse kidney cell lines (BMK) with
either Akt or H-Ras pathway activation, A549 (K-Ras
mutant), MDA-MB-468 (PTEN null), and other cancer
cell lines. The main findings were corroborated in xeno-
graft experiments.
Results
Determination of fatty acid acquisition routes in an iso-
genic model with either Akt or Ras pathway activation
demonstrated that Akt induces de novo fatty acid synth-
esis, whereas Ras decreases it. This was most evident for
the mono-unsaturated fatty acid oleate (C18:1), of which
96% was produced de novo in Akt-driven cells but only
57% in Ras-driven cells. We confirmed that Akt pathway
activation leads to elevated levels of stearoyl-CoA desatur-
ase 1 (SCD1), a key enzyme in the synthesis of oleate, and
that Ras pathway activation leads to increased uptake of
exogenous lipids. We hypothesized that SCD1 inhibition
would therefore be particularly toxic to the Akt-driven
cells. We confirmed that Akt activated cells were signifi-
cantly more sensitive to SCD1 inhibition than those with
Ras activation. Growth of Ras-driven cells was unaffected
by SCD1 inhibition for multiple doublings, after which the
cells stopped growing. We found that growth inhibition
coincided with depletion of lysolipids in the media. This
Ras-dependent phenotype was also observed in A549 cells
(K-Ras mutant) and other cell lines. A xenograft experi-
ment with A549 cells demonstrated that tumor growth in
mice on a diet containing abundant oleate was not affected
by SCD1 inhibition, whereas tumor growth was signifi-
cantly inhibited in mice fed with an oleate poor diet.
Conclusions
This work contributes to explaining at a molecular level
how diet may impact tumor progression. In addition, the
improved understanding of how cancer cells acquire their
lipids will aid future efforts that target lipid metabolism as
an anti-cancer strategy.
Author details
1Lewis-Sigler Institute for Integrative Genomics and Department of
Chemistry, Princeton University, Princeton, New Jersey 08544, USA.
2Cancer
1Lewis-Sigler Institute for Integrative Genomics and Department of
Chemistry, Princeton University, Princeton, New Jersey 08544, USA
Full list of author information is available at the end of the article
Kamphorst et al. BMC Proceedings 2012, 6(Suppl 3):P25
http://www.biomedcentral.com/1753-6561/6/S3/P25
© 2012 Kamphorst et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center,
New York, NY 10065, USA.
3The Cancer Institute of New Jersey, New
Brunswick, New Jersey 08903, USA.
4University of Medicine and Dentistry of
New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey
08854, USA.
5Department of Molecular Biology and Biochemistry, Rutgers
University, Piscataway, New Jersey 08854, USA.
Published: 1 June 2012
doi:10.1186/1753-6561-6-S3-P25
Cite this article as: Kamphorst et al.: Ras-driven cancer cells can
scavenge exogenous lipids to support their proliferation. BMC
Proceedings 2012 6(Suppl 3):P25.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kamphorst et al. BMC Proceedings 2012, 6(Suppl 3):P25
http://www.biomedcentral.com/1753-6561/6/S3/P25
Page 2 of 2